Thymidine

The primary molecular function of Thymidine is its role as a precursor in the DNA salvage pathway, which it exploits to act as a potent biochemical modulator of anti-metabolite chemotherapy. Unlike its use as a traditional drug, thymidine's effect is achieved by manipulating the intracellular balance of deoxyribonucleotide triphosphate (dNTP) pools, which are essential for DNA synthesis and repair. Upon administration, thymidine is rapidly salvaged and phosphorylated by thymidine kinases to form dTTP (deoxythymidine triphosphate). This supplementation significantly increases the intracellular concentration of both dTTP and dGTP pools. This alteration of dNTP balance is directly responsible for thymidine's observed therapeutic effects, which are dependent on the co-administered drug. The elevated dTTP pools influence the metabolism of cytotoxic drugs. For example, it is thought to enhance the activation and incorporation of the active cytotoxic form of 5-Fluorouracil (FU) into DNA and RNA. The increase in dTTP and dGTP is linked to the observed acceleration of DNA replication fork progression in various cell types.